|
Postdoctoral Position Available!
Want to do cutting-edge interdisciplinary research in a
stimulating environment (i.e. University of Toronto at Mississauga)?
Want to live in a nice place (i.e. Toronto and Mississauga)?
Want to gain experience that will certainly assist your career
and job prospects (i.e. excellent placement of previous coworkers)?
Then you should consider joining our lab. Our facilities
are excellent, and we have plenty of space and funding. Please
contact Jumi Shin at jshin@utm.utoronto.caor
(905) 828-5355.
|
Welcome to the Shin Lab homepage at the University of Toronto!
If you are reading this page, you are probably interested in science
and research. Excellent. If you have more questions, please contact
Jumi Shin at jshin@utm.utoronto.ca
or (905) 828-5355.
Our research started at the University of Pittsburgh
in 1995. We moved to the U of T in Summer 2002. Here, at the Mississauga
campus (about 15 miles/23 km from downtown Toronto), we have a
large, highly interactive community of researchers at the
interface of chemistry and biology, including groups in bioinformatics,
biotechnology, and biophysics. The environment here is excellent
for learning and doing cutting-edge science. This campus is committed
to interdisciplinary sciences, as can be seen by the rapidly
expanding infrastructure (lots of new construction), programs (for
instance, the new Biotech programs), and hiring of many new faculty
with interdisciplinary research interests (like me).
In our group, we take a
problem-solving approach to our work in protein
design. We study how proteins, Nature's universal scaffold
for molecular recognition, interact with specific ligands when there
are so many to choose from in the cell. In order to gain an understanding
of this large problem, we use a diverse array of tools from molecular
biology, biochemistry, organic and physical chemistry. We
apply our knowledge to protein design, in particular, design of
proteins that target specific DNA sites. In this way, we may be
able to design new drugs that target specific diseases with fewer
side effects.
Some examples of experiments are shown below.
Click on the photos to see enlarged data graphics.
DNA
Synthesis, Cloning, and PCR. We construct genes that
code for our designed proteins. These genes can be synthesized
on a DNA synthesizer, by using polymerase chain reaction (PCR),
or a combination of both. Genes are then cloned into plasmid DNA.
Bacterial cells are transformed with these engineered plasmids,
and these cells become mini factories for our proteins. The graphic
outlines the basic steps we use to construct a gene using DNA synthesis, PCR, cloning, and transformation.
Protein
Expression and Purification. After growing protein in
transformed cells, the cells are lysed and the contents purified.
This can be seen in the SDS-PAGE gel
showing the purification of protein through different steps: molecular
weight markers (Lane 1), crude cell lysate (Lane 2), after purification
on a metal-ion affinity column (Lane 3), and after size-exclusion
chromatography (Lane 4). After the final purification shown in Lane
4, note the purity of protein (denoted
by the red arrow).
Chromatography: HPLC, FPLC, ion-exchange,
size-exclusion. Typically, more
than one type of chromatography is needed to purify our proteins.
After metal-ion affinity chromatography, we commonly use reverse-phase
HPLC or size-exclusion chromatography.
Gel
Electrophoresis. DNA is separated on low-resolution
agarose gels or high-resolution polyacrylamide gels (PAGE). Proteins
are visualized on PAGE gels followed by immunoblot assay. A high-resolution
DNase I footprinting gel is shown; if our protein (or ligand)
binds to a specific DNA site, it will protect that site from random
DNase I cleavage. This can be seen by the empty space or "footprint"
left by our proteins binding specifically to the AP-1 and ATF/CREB
sites on a ~650 base-pair fragment of DNA. Footprinting is an especially
stringent technique for evaluating specific binding of ligands to
DNA. From this data, we conclude that our
proteins can specifically bind to desired DNA sites.
Circular
Dichroism. We are designing a-helical proteins. This particular structure can be
measured by CD; a-helices display a double minima
at 208 nm and 220 nm. The CD shown here confirms that we
have the desired a-helical
structure for all four of our proteins.
Fluorescence
Anisotropy. In an anisotropy titration, we add aliquots
of protein to fluorescein-labeled DNA in a cuvette. As protein
concentration increases, binding to DNA increases and increases
the anisotropy of the fluoresceinated DNA: i.e. as the protein
binds, the tumbling motion of DNA in solution slows down. This
experiment gives us information on the thermodynamics
of protein-DNA complexation. We generate a binding isotherm
which provides us with the free energy of binding in our system.
This is a terrific experiment; you can do a titration and fit the
data on the computer, and within a couple of hours, you have your
free energy.
Mass
Spectrometry. Measuring the masses of your proteins
can give you valuable information about whether or not you have
the expected protein. Often, post-translational
modifications occur on a protein, so sequencing proteins
using MS is very useful. We have developed techniques for using
MALDI-TOF mass spectrometry to gain
masses of extremely hydrophobic proteins. The graphic shows MALDI-TOF
of one of our proteins: the cystine dimer, matrix adduct, mercaptoethanol
adduct, and protein proteolyzed at the methionine amino terminus
are detected. We also use electrospray ionization MS for studying protein fragments.
|